Application Note
How to mechanically test 3D printed hydrogels with ElastoSens™ Bio
by Dr. Dimitria Bonizol Camasao
Senior Application Specialist, Rheolution Inc.
SUMMARY
- The mechanical characterization of 3D printed scaffolds have been conventionally performed by destructive testing techniques.
- ElastoSens™ Bio has shown to provide reproducible and sensitive measurements of the viscoelastic properties of 3D printed scaffolds.
- The volume fraction and the printing pattern contributed to the mechanical properties of 3D constructs.
Tailored solution for 3D printed scaffold testing
Introduction
3D printing technologies offer the advantage of precisely controlling the microstructure of scaffolds used for tissue engineering applications and drug delivery systems. The macro-mechanical properties of these scaffolds are directly related to their microstructure and both are important parameters for cell behavior and drug release [1,2]. The evaluation of the scaffold mechanical properties has been conventionally performed by destructive, in contact testing techniques (e.g. compression and tensile tests). This prevents the use of the 3D printed scaffold for further characterizations and requires multiple samples to test its mechanical stability over long periods of time. In addition, technical limitation of conventional instruments are usually an issue to precisely measure the soft nature of these scaffolds. In this short application note, the viscoelastic properties of two 3D printed scaffolds made of two different materials were tested using the ElastoSens™ Bio.
Assessing mechanical properties of silicone and poloxamer-based scaffolds
Materials and Methods
RTV silicone rubber (Dow Corning, MI, USA) and poloxamer gel (Allevi, PA, USA) were 3D printed inside the ElastoSens™ Bio sample holder (Fig. 1) to produce scaffolds with different porosities (volume fraction). The Bioscaffolder printer (Analytik, Cambridge, UK) and the Allevi 2 printer (Allevi, PA, USA) were used for printing the silicone and the poloxamer gels, respectively. Scaffold’s volume fraction was calculated as follows:
The printing patterns of the 3D printed silicone scaffolds are shown in Fig. 2. The structure varied in volume fraction (100 %, 75 %, 68 % and 54 %) by adjusting the line width (0.5 mm and 0.8 mm) and the void width (1.16 mm, 0.69 mm and 0.89 mm). A thin layer of silicone was printed between the sample and the holder to ensure their contact in order to meet the testing requirements of the ElastoSens™ Bio.
After the complete gel formation, water was added into the sample holders containing the scaffolds in order to replace the air in the pores. A vacuum chamber was used to produce a negative pressure and force air to be expelled from the scaffold pores. By doing so, the macro density of the scaffold was close to 1.0 (a requirement of the testing method). The scaffolds were then tested in the ElastoSens™ Bio.
Scaffold architecture defines its viscoelastic properties
Results and Discussion
For the poloxamer scaffolds, the storage modulus also decreased when porosity increased as a direct consequence of the lower amount of polymer present in the construct (Fig. 5) (lower volume fraction). Printed scaffolds with 47 % and 43 % of volume fraction had a decrease of 85 % and 88 % in the storage modulus when compared to the bulk gel, respectively.
Conclusion
RTV silicone-based and poloxamer-based scaffolds with different porosities were successfully 3D printed inside ElastoSens™ Bio’s sample holders. Volume fraction and printing pattern showed to impact the mechanical properties of the 3D printed constructs.
Perspectives
- The direct printing inside the sample holder of ElastoSens™ Bio avoids the excessive manipulation of soft and fragile constructs which can cause sample damage and contamination.
- ElastoSens™ Bio is an easy-to-use, non-destructive and contact free instrument that measures the viscoelasticity of 3D printed scaffolds.
- The system offers the possibility to easily tune the mechanical properties of 3D printed scaffolds by altering the composition of the bioink as well as the printing pattern [3].
- Testing the mechanical evolution of the same sample over short or long periods of time is now possible thanks to the non destructive nature of ElastoSens™ Bio.
- ElastoSens™ Bio allows testing the viscoelasticity of biomaterials under different physical (e.g. photo or thermo stimulation), chemical (e.g. crosslinking solution) and physiological (e.g. enzymatic solution) conditions to simulate in vivo behaviors.
ElastoSens™ Bio
ElastoSens™ Bio
REFERENCES
[1] Woo Lee, J., & Cho, D. W. (2015). 3D Printing technology over a drug delivery for tissue engineering. Current Pharmaceutical Design, 21(12), 1606-1617.
[2] Chen, Z., Zhao, D., Liu, B., Nian, G., Li, X., Yin, J., … & Yang, W. (2019). 3D Printing of Multifunctional Hydrogels. Advanced Functional Materials, 29(20), 1900971.
[3] Godau, B. (2019). Determining the effect of structure and function on 3D bioprinted hydrogel scaffolds for applications in tissue engineering (Master dissertation).
ACKNOWLEDGEMENT
Related Posts
Ever fantasized about sci-fi healing tanks? The principle of neutral buoyancy behind them has sparked a unique solution for 3D printing with soft, liquid-like inks. The Freeform Reversible Embedding of Suspended Hydrogels (FRESH) bioprinting technique has been developed to support the printing of these tricky materials, ideal for tissue engineering applications. The secret lies in a cleverly engineered support bath, able to hold the soft structures while permitting extruder needle movement. With versatility, high cell viability, and potential for large construct printing, FRESH opens up a world of possibilities, bringing us a step closer to 3D bioprinting patient-specific tissues based on anatomical data.
Exploring the frontier of 3D printing, Cornell University researchers have enhanced the Freeform Reversible Embedding of Suspended Hydrogels (FRESH) method. They introduced a computational approach for non-planar printing, enabling complex curved structures, improving printing accuracy and augmenting the mechanical properties of bioprints.
4D bioprinting introduces "time" as the fourth dimension, enabling printed objects to change over time. Physical stimuli like light, temperature, or magnetism can induce transformations. The bioprinting process can also allow targeted drug release through changes in temperature or pH. Nano-hydrogels can serve as drug carriers, directed by magnetic fields, and can be quickly degraded by enzymes. Furthermore, hydrogels can react to biological signals, aiding in tumor treatment by releasing drugs then biodegrading over time.
4D-bioprinting introduces "time" into the printing process, allowing printed structures to evolve. Researchers from the University of Illinois Chicago used oxidized and methacrylated alginate (OMA) to develop a bioink for 4D bioprinting. They made OMA into precursor beads, then transformed them into a "microgel" that could be easily printed into stable 3D constructs. Mixed with cells, the microgel became a bioink, which was printed into complex structures. The printed constructs could be further crosslinked to create 3D scaffolds that could change shape due to differential swelling, adding the 4th dimension, "time," to the printing process.
3D-bioprinting involves printing a biomaterial or 'bioink' that contains cells, forming structures similar to living tissues. The process requires careful optimization to ensure the material holds its shape and function, and that the cells survive the printing process. Current bioprinting techniques, such as extrusion, inkjet and laser-assisted bioprinting, come with their own advantages and limitations. The ultimate goal is to bring in vitro bioprinting into the operating room, overcoming challenges like sterility, regulation, and ethical considerations.
Recent advancements in 3D-bioprinting have opened the possibility of creating engineered tissues mimicking human native tissues. However, reproducing the extracellular matrix (ECM) composition and microscopic architecture within the biomaterial ink remains challenging. To tackle this, a research group from the AO Research Institute Davos developed a bioink containing both collagen type 1 and tyramine derivative hyaluronan for tissue engineering. They used optimal concentrations of these two components, along with human bone marrow-derived mesenchymal stromal cells. Two crosslinking pathways were used to induce gelation and create a 3D scaffold that was then printed using the bioink's shear-thinning properties. They successfully printed an anisotropic hydrogel, achieving control over the microscopic organization of the matrix. This breakthrough could pave the way for better mimicry of native human tissues, especially anisotropic ones, in tissue engineering applications.